Dual-controlled release of PTH(1–34) via microsphere-hydrogel scaffold promotes early bone regeneration in osteoporosis
Source abstract
Abstract
This study developed a three-dimensional (3D)-printed dual-controlled release scaffold for localized, sustained parathyroid hormone 1–34 (PTH 1–34) delivery to overcome systemic limitations (inadequate spatiotemporal control, poor anatomical matching) and enhance early bone regeneration in osteoporotic defects. PTH(1–34)-loaded poly(lactic- co -glycolic acid) (PLGA) microspheres (68.2 % efficiency) were incorporated into chitosan (CS) /short rod-shaped nano-hydroxyapatite (nHA) hydrogel ink and 3D-printed (300 μm nozzle). In vitro, scaffolds exhibited sustained biphasic release (19.4 ± 2.1 % initial burst within 24 h and 71.8 ± 1.7 % cumulative release over 30 days), significantly promoting MC3T3-E1 proliferation, alkaline phosphatase (ALP) activity (3.08-fold vs control, day 14; p < 0.01), and runt-related transcription factor 2 (Runx2) expression (8.13-fold; p < 0.001). In vivo (Ovariectomy rats, 5-mm calvarial defects; n = 5/group), Micro-computed tomography (micro-CT) at 4 weeks showed 2.22-fold higher trabecular bone volume fraction (BV/TV) ( p < 0.001) with 73 % greater trabecular thickness ( p < 0.001), confirmed histologically by accelerated mineralization/osteoblast activation. The PTH(1–34)@PLGA/CS-nHA scaffold integrates spatiotemporal drug delivery and biomimetic architecture, offering a promising strategy for early-phase bone regeneration in osteoporosis.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone health and treatments · Bone health and osteoporosis research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Biomaterial design for regenerating aged bone: materiobiological advances and paradigmatic shifts10.1093/nsr/nwae076 ↗
2. Exosomes from young plasma alleviate osteoporosis through miR-217-5p-regulated osteogenesis of bone marrow mesenchymal stem cell10.1016/j.compositesb.2024.111358 ↗
3. Injectable magnesium-bisphosphonate MOF-based bone adhesive prevents excessive fibrosis for osteoporotic fracture repair10.1038/s41467-025-60853-8 ↗
4. An Jeung Hee, dual-action ascorbic acid–maghemite hybrid nanoparticles enhance osteoblast activity and suppress osteoclast activity in osteoporosis10.1016/j.matdes.2025.114523 ↗
5. Fishnet-inspired 3D scaffold fabricated from mesh-like electrospun membranes promoted osteoporotic bone regeneration10.1007/s42765-024-00451-3 ↗
6. Short-term Administration of Parathyroid Hormone Improves Wound Healing around Implants in an osteoporotic rat model10.3390/jcm14113900 ↗
7. An injectable antioxidant parathyroid hormone related supramolecular peptide nanofiber hydrogel for repairing osteoporotic bone defects10.1021/acsami.5c06674 ↗
8. Early effects of parathyroid hormone on vascularized bone regeneration and implant osseointegration in aged rats10.1016/j.biomaterials.2018.06.035 ↗
9. PTH receptor signalling, osteocytes and bone disease induced by diabetes mellitus10.1038/s41574-024-01014-7 ↗
10. An integrated microcurrent delivery system facilitates human parathyroid hormone delivery for enhancing Osteoanabolic effect10.1002/smtd.202401144 ↗
11. Classification and bibliometric analysis of hydrogels in periodontitis treatment: trends, mechanisms, advantages, and future research directions10.1016/j.dental.2024.10.017 ↗
12. 3D-printed bone regeneration scaffolds modulate bone metabolic homeostasis through vascularization for osteoporotic bone defects10.1016/j.biomaterials.2024.122699 ↗
13. A mechanical-assisted post-bioprinting strategy for challenging bone defects repair10.1038/s41467-024-48023-8 ↗
14. Horseradish peroxidase-catalyzed crosslinking injectable hydrogel for bone repair and regeneration
15. Recent advances and perspectives in functional chitosan-based composites for environmental remediation, energy, and biomedical applications
16. Chitosan modified with PAP as a promising delivery system for melatonin in the treatment of osteoporosis10.1186/s13036-024-00422-7 ↗
17. Recent advances in engineering chitosan-based nanoplatforms in biotherapeutic multi-delivery for multi-targeted disease treatments: promises and outlooks
18. Modulating the rigidity and mineralization of collagen gels using poly(lactic-co-glycolic acid) microparticles10.1089/ten.tea.2011.0547 ↗
19. Nanoparticle-based drug delivery systems: an updated strategy for treating fungal keratitis
20. Phase composition of calcium phosphate materials affects bone formation by modulating osteoclastogenesis10.1016/j.actbio.2024.01.022 ↗
21. Dual-Cross-Linked Magnetic hydrogel with programmed release of parathyroid hormone promotes bone healing10.1021/acsami.3c03047 ↗
22. Simultaneous incorporation of PTH(1-34) and nano-hydroxyapatite into chitosan/alginate hydrogels for efficient bone regeneration
23. 3D printing for bone regeneration: challenges and opportunities for achieving predictability
24. Electrospunned nanofiber membranes of PTH-related peptide loaded biopolymers for osteoporotic bone defect repair10.1016/j.matdes.2024.113179 ↗
25. DNA aptamer immobilized hydroxyapatite for enhancing angiogenesis and bone regeneration10.1016/j.actbio.2019.08.047 ↗
26. Porous PLGA microspheres loaded with PTH(1-34) peptide for long-term treatment of OA10.1016/j.jot.2025.05.003 ↗
27. Biomimetic hydroxyapatite nanorods promote bone regeneration via accelerating osteogenesis of BMSCs through T cell-derived IL-2210.1021/acsnano.1c08281 ↗
28. Altered mechanical environment of bone cells in an animal model of short- and long-term osteoporosis10.1016/j.bpj.2015.02.031 ↗
29. OPG gene-modified adipose-derived stem cells improve bone formation around implants in osteoporotic rat maxillae10.1016/j.heliyon.2023.e19474 ↗
30. Enhanced bone regeneration via local low-dose delivery of PTH(1-34) in a composite hydrogel